Stevenato Group S.A. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Stevenato Group S.A. | STVN - NYSE |
$21.00-$24.00 | $21.00 | $16.65 | 32 million | 7/16/2021 |
| Morgan Stanley, BofA Securities, Jefferies, Citigroup, KeyBanc Capital, UBS Investment, Wells Fargo, William Blair | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-21 Terms Added 2021-07-07 | ||||||
Stevenato Group S.A. Quote & Chart - Click for current quote - STVN
IPO Boutique aggregates information on public companies and private companies, such as "STVN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Stevenato Group S.A. (adapted from Stevenato Group S.A. prospectus):
They are a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "STVN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.